The Wolverine Stack

The 'Wolverine stack' (also sold as the Wolverine blend) isn't a single drug. It's two peptides run together: BPC-157 and TB-500 (thymosin beta-4). The name is a nod to the Marvel character's healing factor, and the term comes out of the 'optimisation medicine' and biohacking scene rather than any clinical literature.

It's pitched as the ultimate recovery combo, and the sales story neatly splits the work in two: BPC-157 is said to set up the conditions for healing (new blood vessels, growth factors) while TB-500 is said to mobilise the cells that do the repair. Clinics and recovery influencers market it for bouncing back from strains, sprains and even post-surgery, often promising visible results within a few weeks. It's one of the most-searched peptide stacks precisely because that promise is exactly what an injured lifter wants to hear.

Notice who's telling that story: almost everyone making the recovery claims is also selling the injections. The 'results in a couple of weeks' lines are marketing and anecdote, not finished human trials. On our scale both peptides are Grade D, meaning the encouraging healing data is overwhelmingly from rats and cell cultures. Stacking two D-grade peptides doesn't add up to human evidence; it just stacks the unknowns. Both also carry anti-doping flags (check each peptide's page), so for any tested athlete this is a ban risk, and as unlicensed products there's no guarantee of what's actually in the vial. None of that proves it doesn't work; it means nobody has shown that it does, in humans, yet.

Neither BPC-157 nor TB-500 is a licensed medicine in the UK. Both are sold as unlicensed 'research chemicals', so there is no MHRA check on what is in the vial. See each peptide's page below for the full UK legal and anti-doping detail.